Ann E McCullough Selected Research

Ann E McCullough Research Topics

Disease

29	Neoplasms (Cancer) 01/2021 - 03/2002
22	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
5	Triple Negative Breast Neoplasms 11/2017 - 02/2014
2	Pathologic Complete Response 06/2020 - 04/2016
2	Adenocarcinoma 01/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 12/2017 - 01/2007
2	Margins of Excision 04/2011 - 03/2002
2	Merkel Cell Carcinoma 01/2007 - 03/2002
1	Carcinoma (Carcinomatosis) 01/2022
1	Residual Neoplasm 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Aneuploidy (Aneuploid) 11/2018
1	Tetraploidy 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 02/2016
1	Hyperplasia 02/2016
1	Hemangiosarcoma (Angiosarcoma) 02/2016
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016
1	Cholangiocarcinoma 02/2014
1	Cardiotoxicity 04/2013
1	Diarrhea 04/2013
1	Heart Failure 06/2012
1	Amyloidosis 06/2012
1	Ductal Carcinoma 05/2012
1	Pelvic Pain 02/2011
1	Leiomyoma (Uterine Fibroids) 02/2011
1	Endometriosis 02/2011
1	Endometrial Hyperplasia 02/2011
1	Osteosarcoma (Osteogenic Sarcoma) 12/2010
1	Leukemia 12/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2008

Drug/Important Bio-Agent (IBA)

8	Trastuzumab (Herceptin)FDA Link 01/2021 - 02/2011
8	Estrogen ReceptorsIBA 08/2017 - 10/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2015
5	ErbB Receptors (EGF Receptor)IBA 04/2016 - 01/2010
4	human ERBB2 proteinIBA 02/2016 - 12/2010
3	Lapatinib (GW572016)FDA Link 01/2021 - 04/2013
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 02/2014
3	OligonucleotidesIBA 11/2018 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 08/2017 - 12/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2017 - 10/2010
2	Epidermal Growth Factor (EGF)IBA 04/2016 - 02/2014
2	Hormones (Hormone)IBA 08/2015 - 10/2013
2	Messenger RNA (mRNA)IBA 03/2015 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2015 - 12/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2015 - 01/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	AntibodiesIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Folate Receptor 1IBA 01/2015
1	Tamoxifen FDA LinkGeneric 10/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2014
1	Androgen Receptors (Androgen Receptor)IBA 02/2014
1	Pharmaceutical PreparationsIBA 02/2014
1	Phosphotransferases (Kinase)IBA 02/2014
1	pazopanib FDA Link 02/2014
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 06/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2013
1	Amyloid (Amyloid Fibrils)IBA 06/2012
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2012
1	Formaldehyde (Formol)FDA Link 12/2010
1	Wnt-5a ProteinIBA 12/2010
1	ParaffinIBA 12/2010
1	Cyclin A2IBA 12/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2010
1	SurvivinIBA 12/2010
1	GRB7 Adaptor ProteinIBA 12/2010
1	Contrast MediaIBA 03/2009
1	Methotrexate (Mexate)FDA LinkGeneric 03/2008

Therapy/Procedure

12	Therapeutics 06/2020 - 03/2002
5	Drug Therapy (Chemotherapy) 01/2021 - 06/2013
3	Neoadjuvant Therapy 01/2022 - 12/2017
2	Lymph Node Excision (Lymph Node Dissection) 06/2020 - 01/2007
2	Radiotherapy 02/2016 - 03/2002
1	Molecular Targeted Therapy 11/2017
1	Chemoprevention 07/2017
1	Combination Drug Therapy (Combination Chemotherapy) 03/2015
1	Aftercare (After-Treatment) 06/2012
1	Segmental Mastectomy (Lumpectomy) 05/2012
1	Mastectomy (Mammectomy) 04/2011
1	Hysterectomy 02/2011
1	Morcellation 02/2011
1	Adjuvant Chemotherapy 01/2010